Legend Biotech logo — Multinational biopharmaceutical company focused on discoveri...

Legend Biotech

Multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies

Founded 2014 United States Somerset, United States 2565 employees Total: $1.62B Biotechnology, Health Care +2

General Information

Company Name Legend Biotech
Founded Year 2014
Location United States Somerset, United States
Employees 2565
Industries Biotechnology, Health Care, Health and Wellness +1
Business Model B2B, B2D
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Legend Biotech. To contact Legend Biotech, visit legendbiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Legend Biotech compare?

A PDF of Legend Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Legend Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Legend Biotech

Legend Biotech, founded in 2014, is a rapidly advancing multinational biopharmaceutical company headquartered in the United States. The company is focused on discovering and developing cutting-edge cell-based therapies to address critical health needs. Operating across vital sectors like Biotechnology, Health Care, and Life Sciences, Legend Biotech expertly navigates the complexities of the global healthcare industry.

With its corporate headquarters in Somerset, NJ, and manufacturing facilities strategically located in the United States, China, and Belgium, the company ensures a broad international footprint and streamlined operations. Recent funding activities include a significant $350.00M private placement VC investment secured in May 2023, underscoring investor confidence in its innovative pipeline and commercialization strategies.

Legend Biotech's commitment to leveraging cutting-edge technologies positions it as a compelling prospect for further investment, driven by a mission to yield impactful therapeutic advancements worldwide.

Business keywords: Biopharmaceutical, Cell-Based Therapies, Cell Therapy, Chimeric Antigen Receptor T-cell (CAR-T), Natural Killer (NK) Cell-based Immunotherapy, Oncology, Manufacturing Facilities, Clinical-Stage Therapeutics, R&D, Novel Therapies, Multiple Myeloma Treatment, Autologous Cell Therapy, Allogeneic Cell Therapy, Advanced Technology Platforms

Services & Products

End-to-end Cell Therapy Development
Drug Discovery
Clinical Trials
Commercialization of Therapies
Scientific Research and Publications

Target Customers

Patients with Hematologic Malignancies Patients with Solid Tumors Healthcare Professionals Oncologists Biopharmaceutical Investors

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Private Placement VC $350.00M -
01 May 2023
Post-IPO Equity $350.00M -
01 Jul 2022
Post-IPO Equity $500.00M 1
Hillhouse Capital
01 May 2021
Series A $423.80M -
01 Jun 2020

Legend Biotech Alternatives & Competitors

View All Alternatives
Legend Biotech vs
Adaptimmune
Adaptimmune United Kingdom

Designing and delivering cell therapies to transform the lives of people with cancer.

Post-IPO Debt
200 employees
Biopharma, Biotechnology
Legend Biotech vs
Adicet Bio, Inc
Adicet Bio, Inc United States

A biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell...

IPO
124 employees
Biopharma, Biotechnology
Legend Biotech vs
Caribou Biosciences
Caribou Biosciences United States

Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating hu...

IPO
128 employees
Biotechnology, Health Care

FAQ About Legend Biotech

Multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies
Legend Biotech was founded in 2014.
Legend Biotech is headquartered in Somerset, United States.
Legend Biotech operates in Biotechnology, Health Care, Health and Wellness and Life Sciences. Its work centres on Biopharmaceutical, Cell-Based Therapies, Cell Therapy and Chimeric Antigen Receptor T-cell (CAR-T). Its customers include Patients with Hematologic Malignancies, Patients with Solid Tumors and Healthcare Professionals.
Legend Biotech has a B2B and B2D business model. Its revenue comes from Product Sales and Licensing.
Legend Biotech has approximately 2565 employees.
Legend Biotech has completed 4 funding rounds, raising a total of $1.62B.
Legend Biotech offers: End-to-end Cell Therapy Development, Drug Discovery, Clinical Trials, Commercialization of Therapies, Scientific Research and Publications.
Top alternatives and competitors to Legend Biotech include Adaptimmune, Adicet Bio, Inc, Caribou Biosciences, Marker Therapeutics, Inc., Arcellx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Legend Biotech and Adaptimmune are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Legend Biotech, https://bouncewatch.com/company/legend-biotech, updated 4 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes